应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RAPT RAPT Therapeutics, Inc.
盘后交易 12-05 19:12:27 EST
34.47
+0.00
-0.01%
盘后
33.82
-0.65
-1.87%
18:43 EST
最高
35.72
最低
33.90
成交量
36.37万
今开
34.47
昨收
34.47
日振幅
5.28%
总市值
9.55亿
流通市值
4.57亿
总股本
2,771万
成交额
1,250万
换手率
2.74%
流通股本
1,326万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
RAPT Therapeutics启动Ozureprubart(Rpt904)在食物过敏患者中的Prestige 2B期临床试验
美股速递 · 10-27
RAPT Therapeutics启动Ozureprubart(Rpt904)在食物过敏患者中的Prestige 2B期临床试验
RAPT Therapeutics 股价因中国实验性皮肤病药物积极试验数据上涨 43.2%
美股速递 · 10-20
RAPT Therapeutics 股价因中国实验性皮肤病药物积极试验数据上涨 43.2%
RAPT Therapeutics股价在盘前交易中上涨95%,因中国临床试验数据显示实验性皮肤病药物效果良好
美股速递 · 10-20
RAPT Therapeutics股价在盘前交易中上涨95%,因中国临床试验数据显示实验性皮肤病药物效果良好
RAPT Therapeutics与上海杰优制药宣布Rpt904(Jyb1904)在慢性自发性荨麻疹的Ⅱ期试验中取得积极初步数据
美股速递 · 10-20
RAPT Therapeutics与上海杰优制药宣布Rpt904(Jyb1904)在慢性自发性荨麻疹的Ⅱ期试验中取得积极初步数据
RAPT Therapeutics将公布Rpt904在慢性自发性荨麻疹(Csu)二期临床试验的关键数据
美股速递 · 10-19
RAPT Therapeutics将公布Rpt904在慢性自发性荨麻疹(Csu)二期临床试验的关键数据
RAPT Therapeutics宣布FDA批准IND申请,将开展RPT904食物过敏2B期试验
美股速递 · 09-29
RAPT Therapeutics宣布FDA批准IND申请,将开展RPT904食物过敏2B期试验
RAPT Therapeutics股价盘前上涨3.1%,Leerink Partners将评级从"市场表现"上调至"跑赢大盘"
美股速递 · 09-26
RAPT Therapeutics股价盘前上涨3.1%,Leerink Partners将评级从"市场表现"上调至"跑赢大盘"
Rapt Therapeutics, Inc.盘中异动 股价大涨5.67%报17.14美元
市场透视 · 09-15
Rapt Therapeutics, Inc.盘中异动 股价大涨5.67%报17.14美元
Rapt Therapeutics, Inc.2024财年实现净利润-1.30亿美元,同比减少11.11%
市场透视 · 03-10
Rapt Therapeutics, Inc.2024财年实现净利润-1.30亿美元,同比减少11.11%
RAPT Therapeutics 第四季度每股收益$(1.14)低于预期$(0.36)
财报速递 · 03-06
RAPT Therapeutics 第四季度每股收益$(1.14)低于预期$(0.36)
Rapt Therapeutics, Inc.盘中异动 临近收盘大幅下跌5.13%报1.11美元
市场透视 · 02-28
Rapt Therapeutics, Inc.盘中异动 临近收盘大幅下跌5.13%报1.11美元
Rapt Therapeutics, Inc.盘中异动 快速上涨5.00%报1.26美元
市场透视 · 02-18
Rapt Therapeutics, Inc.盘中异动 快速上涨5.00%报1.26美元
Rapt Therapeutics, Inc.盘中异动 下午盘股价大跌5.33%报1.16美元
市场透视 · 01-24
Rapt Therapeutics, Inc.盘中异动 下午盘股价大跌5.33%报1.16美元
Rapt Therapeutics, Inc.盘中异动 股价大涨5.00%
市场透视 · 01-21
Rapt Therapeutics, Inc.盘中异动 股价大涨5.00%
Rapt Therapeutics, Inc.盘中异动 早盘快速上涨8.18%报1.19美元
市场透视 · 01-15
Rapt Therapeutics, Inc.盘中异动 早盘快速上涨8.18%报1.19美元
Rapt Therapeutics, Inc.盘中异动 早盘大幅下挫5.63%报1.51美元
市场透视 · 01-08
Rapt Therapeutics, Inc.盘中异动 早盘大幅下挫5.63%报1.51美元
Rapt Therapeutics, Inc.盘中异动 早盘急速跳水5.23%
市场透视 · 01-07
Rapt Therapeutics, Inc.盘中异动 早盘急速跳水5.23%
Rapt Therapeutics, Inc.盘中异动 股价大涨5.52%
市场透视 · 01-03
Rapt Therapeutics, Inc.盘中异动 股价大涨5.52%
Rapt Therapeutics, Inc.盘中异动 下午盘快速拉升5.25%
市场透视 · 01-01
Rapt Therapeutics, Inc.盘中异动 下午盘快速拉升5.25%
Rapt Therapeutics, Inc.盘中异动 大幅上涨5.52%
市场透视 · 2024-12-27
Rapt Therapeutics, Inc.盘中异动 大幅上涨5.52%
加载更多
公司概况
公司名称:
RAPT Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
RAPT Therapeutics, Inc.根据特拉华州法律于2015年3月注册成立。该公司是一家临床阶段,以免疫学为基础的生物制药公司,致力于发现,开发和商业化针对在肿瘤学和炎性疾病方面尚未得到充分满足的患者的口服小分子疗法。利用其专有的药物发现和开发引擎,该公司开发了高度选择性小分子,旨在调节这些疾病的关键免疫反应。
发行价格:
--
{"stockData":{"symbol":"RAPT","market":"US","secType":"STK","nameCN":"RAPT Therapeutics, Inc.","latestPrice":34.465,"timestamp":1764968400000,"preClose":34.47,"halted":0,"volume":363676,"hourTrading":{"tag":"盘后","latestPrice":33.82,"preClose":34.465,"latestTime":"18:43 EST","volume":3067,"amount":105696.223738,"timestamp":1764978239443},"delay":0,"floatShares":13255600,"shares":27710871,"eps":-6.596857,"marketStatus":"盘后交易","change":-0.005,"latestTime":"12-05 19:12:27 EST","open":34.47,"high":35.72,"low":33.9,"amount":12495270.927,"amplitude":0.0528,"askPrice":35.14,"askSize":56,"bidPrice":33.8,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-6.596857,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1764982800000},"marketStatusCode":4,"adr":0,"listingDate":1572494400000,"exchange":"NASDAQ","adjPreClose":34.47,"preHourTrading":{"tag":"盘前","latestPrice":35,"preClose":34.47,"latestTime":"08:00 EST","volume":1,"amount":35,"timestamp":1764939604788},"postHourTrading":{"tag":"盘后","latestPrice":33.82,"preClose":34.465,"latestTime":"18:43 EST","volume":3067,"amount":105696.223738,"timestamp":1764978239443},"volumeRatio":0.837166,"impliedVol":0.8019,"impliedVolPercentile":0.2209},"requestUrl":"/m/hq/s/RAPT","defaultTab":"news","newsList":[{"id":"1190261155","title":"RAPT Therapeutics启动Ozureprubart(Rpt904)在食物过敏患者中的Prestige 2B期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1190261155","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190261155?lang=zh_cn&edition=full","pubTime":"2025-10-27 20:02","pubTimestamp":1761566577,"startTime":"0","endTime":"0","summary":"RAPT Therapeutics启动Ozureprubart(Rpt904)在食物过敏患者中的Prestige 2B期临床试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPT","BK4139"],"gpt_icon":0},{"id":"1156143109","title":"RAPT Therapeutics 股价因中国实验性皮肤病药物积极试验数据上涨 43.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156143109","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156143109?lang=zh_cn&edition=full","pubTime":"2025-10-20 21:33","pubTimestamp":1760967191,"startTime":"0","endTime":"0","summary":"RAPT Therapeutics 股价因中国实验性皮肤病药物的积极试验数据上涨 43.2%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPT","BK4139"],"gpt_icon":0},{"id":"1145187079","title":"RAPT Therapeutics股价在盘前交易中上涨95%,因中国临床试验数据显示实验性皮肤病药物效果良好","url":"https://stock-news.laohu8.com/highlight/detail?id=1145187079","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145187079?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:51","pubTimestamp":1760964669,"startTime":"0","endTime":"0","summary":"RAPT Therapeutics股价在盘前交易中上涨95%,因中国临床试验数据显示实验性皮肤病药物效果良好","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPT","BK4139"],"gpt_icon":0},{"id":"1102462553","title":"RAPT Therapeutics与上海杰优制药宣布Rpt904(Jyb1904)在慢性自发性荨麻疹的Ⅱ期试验中取得积极初步数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1102462553","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102462553?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:01","pubTimestamp":1760961697,"startTime":"0","endTime":"0","summary":"RAPT Therapeutics与上海杰优制药宣布Rpt904(Jyb1904)在慢性自发性荨麻疹的Ⅱ期试验中取得积极初步数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPT","BK4139"],"gpt_icon":0},{"id":"1119022708","title":"RAPT Therapeutics将公布Rpt904在慢性自发性荨麻疹(Csu)二期临床试验的关键数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1119022708","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119022708?lang=zh_cn&edition=full","pubTime":"2025-10-19 20:01","pubTimestamp":1760875270,"startTime":"0","endTime":"0","summary":"RAPT Therapeutics将公布Rpt904在慢性自发性荨麻疹(Csu)二期临床试验的关键数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPT","BK4139"],"gpt_icon":0},{"id":"1189766339","title":"RAPT Therapeutics宣布FDA批准IND申请,将开展RPT904食物过敏2B期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1189766339","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189766339?lang=zh_cn&edition=full","pubTime":"2025-09-29 17:08","pubTimestamp":1759136920,"startTime":"0","endTime":"0","summary":"RAPT Therapeutics宣布FDA批准IND申请,将开展RPT904食物过敏2B期试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RAPT"],"gpt_icon":0},{"id":"1107402750","title":"RAPT Therapeutics股价盘前上涨3.1%,Leerink Partners将评级从\"市场表现\"上调至\"跑赢大盘\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1107402750","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107402750?lang=zh_cn&edition=full","pubTime":"2025-09-26 18:47","pubTimestamp":1758883674,"startTime":"0","endTime":"0","summary":"RAPT Therapeutics股价在盘前交易中上涨3.1%,此前Leerink Partners将该股评级从\"市场表现\"上调至\"跑赢大盘\"。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPT","BK4139"],"gpt_icon":0},{"id":"2567145175","title":"Rapt Therapeutics, Inc.盘中异动 股价大涨5.67%报17.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567145175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567145175?lang=zh_cn&edition=full","pubTime":"2025-09-15 23:05","pubTimestamp":1757948738,"startTime":"0","endTime":"0","summary":"北京时间2025年09月15日23时05分,Rapt Therapeutics, Inc.股票出现异动,股价快速上涨5.67%。Rapt Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.16%。其相关个股中,Monte Rosa Therapeutics, Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博涨幅较大,Salarius Pharmaceuticals, Inc.、Nucana Plc、Atyr Pharma, Inc.较为活跃,换手率分别为553.99%、99.02%、97.11%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、冠科美博、Cognition Therapeutics, Inc.,振幅分别为46.37%、38.07%、33.18%。Rapt Therapeutics, Inc.公司简介:RAPT Therapeutics Inc 是一家以免疫学为基础的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509152305389793d40a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509152305389793d40a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RAPT","LENZ","BK4539"],"gpt_icon":0},{"id":"2518281156","title":"Rapt Therapeutics, Inc.2024财年实现净利润-1.30亿美元,同比减少11.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518281156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518281156?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536074,"startTime":"0","endTime":"0","summary":"3月10日,Rapt Therapeutics, Inc.公布财报,公告显示公司2024财年净利润为-1.30亿美元,同比减少11.11%;其中营业收入为0.00美元,每股基本收益为-3.19美元。从资产负债表来看,Rapt Therapeutics, Inc.总负债50.42百万美元,其中短期债务2.42百万美元,资产负债比为0.05,流动比率为0.05。机构评级:截至2025年3月10日,当前有3家机构对Rapt Therapeutics, Inc.目标价做出预测,其中目标均价为6.00美元,其中最低目标价为2.00美元,最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000223a2689865&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000223a2689865&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPT"],"gpt_icon":0},{"id":"1178508796","title":"RAPT Therapeutics 第四季度每股收益$(1.14)低于预期$(0.36)","url":"https://stock-news.laohu8.com/highlight/detail?id=1178508796","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178508796?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:46","pubTimestamp":1741268789,"startTime":"0","endTime":"0","summary":"RAPT Therapeutics(LENZ)第四季度每股收益为$(1.14),低于预期的$(0.36)以上内容来自Benzinga Earnings专栏,原文如下:RAPT $Therapeutics(LENZ)$ Q4 EPS $(1.14) Misses $(0.36) Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"RAPT Therapeutics 第四季度每股收益$(1.14)低于预期$(0.36)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPT"],"gpt_icon":0},{"id":"2514305573","title":"Rapt Therapeutics, Inc.盘中异动 临近收盘大幅下跌5.13%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514305573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514305573?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:37","pubTimestamp":1740688665,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时37分,Rapt Therapeutics, Inc.股票出现异动,股价大幅下跌5.13%。Rapt Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.40%。其相关个股中,Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃,换手率分别为1937.55%、397.06%、196.66%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation,振幅分别为86.14%、67.32%、55.84%。Rapt Therapeutics, Inc.公司简介:RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228043746a256cb82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228043746a256cb82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPT","LENZ","BK4139"],"gpt_icon":0},{"id":"2512165418","title":"Rapt Therapeutics, Inc.盘中异动 快速上涨5.00%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165418?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:36","pubTimestamp":1739889366,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时36分,Rapt Therapeutics, Inc.股票出现异动,股价急速拉升5.00%。Rapt Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.09%。其相关个股中,Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Cardio Diagnostics Holdings Inc C/Wts To Pur Com涨幅较大,Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为286.19%、100.98%、75.77%,振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.、Conduit Pharmaceuticals Inc.,振幅分别为34.04%、22.30%、20.73%。Rapt Therapeutics, Inc.公司简介:RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223606abd3b040&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223606abd3b040&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPT","BK4139"],"gpt_icon":0},{"id":"2505028768","title":"Rapt Therapeutics, Inc.盘中异动 下午盘股价大跌5.33%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505028768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505028768?lang=zh_cn&edition=full","pubTime":"2025-01-24 03:49","pubTimestamp":1737661767,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日03时49分,Rapt Therapeutics, Inc.股票出现波动,股价大幅下挫5.33%。Rapt Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.30%。其相关个股中,Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.涨幅较大,Dogwood Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为7034.83%、6475.63%、804.44%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Hepion Pharmaceuticals, Inc.,振幅分别为948.57%、145.99%、119.04%。Rapt Therapeutics, Inc.公司简介:RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240349279870f1ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240349279870f1ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPT","BK4139","LENZ"],"gpt_icon":0},{"id":"2505571272","title":"Rapt Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505571272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505571272?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:58","pubTimestamp":1737471480,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时58分,Rapt Therapeutics, Inc.股票出现波动,股价急速拉升5.00%。Rapt Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.13%。其相关个股中,Channel Therapeutics Corporation、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Genelux Corporation涨幅较大,Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃,换手率分别为643.03%、172.11%、168.93%,振幅较大的相关个股有Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Genelux Corporation,振幅分别为92.63%、38.48%、22.35%。Rapt Therapeutics, Inc.公司简介:RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121225801a22a5d22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121225801a22a5d22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPT","BK4139","LENZ"],"gpt_icon":0},{"id":"2503642410","title":"Rapt Therapeutics, Inc.盘中异动 早盘快速上涨8.18%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503642410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503642410?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:34","pubTimestamp":1736951644,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时34分,Rapt Therapeutics, Inc.股票出现异动,股价快速上涨8.18%。截至发稿,该股报1.19美元/股,成交量2.5262万股,换手率0.07%,振幅5.45%。Rapt Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.94%。其相关个股中,Generation Bio Co.、Exicure, Inc.、Allovir, Inc.涨幅较大,Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃,换手率分别为185.77%、57.99%、35.72%,振幅较大的相关个股有Onconetix, Inc.、Eterna Therapeutics Inc.、Klotho Neurosciences, Inc.,振幅分别为14.29%、12.79%、12.00%。Rapt Therapeutics, Inc.公司简介:RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522340498673bcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522340498673bcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RAPT"],"gpt_icon":0},{"id":"2502772942","title":"Rapt Therapeutics, Inc.盘中异动 早盘大幅下挫5.63%报1.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502772942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502772942?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:35","pubTimestamp":1736346940,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时35分,Rapt Therapeutics, Inc.股票出现异动,股价快速下跌5.63%。Rapt Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.05%。其相关个股中,Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大,Silo Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃,换手率分别为1080.85%、525.21%、505.25%,振幅较大的相关个股有Silo Pharma, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Sana Biotechnology, Inc.,振幅分别为87.16%、68.53%、66.67%。Rapt Therapeutics, Inc.公司简介:RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223540a21a5424&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223540a21a5424&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RAPT","LENZ"],"gpt_icon":0},{"id":"2501789520","title":"Rapt Therapeutics, Inc.盘中异动 早盘急速跳水5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501789520","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501789520?lang=zh_cn&edition=full","pubTime":"2025-01-07 23:01","pubTimestamp":1736262105,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日23时01分,Rapt Therapeutics, Inc.股票出现波动,股价急速跳水5.23%。Rapt Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.39%。其相关个股中,Hoth Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大,Hoth Therapeutics, Inc.、Immuneering Corporation、Scisparc Ltd.较为活跃,换手率分别为1365.84%、197.31%、117.35%,振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Hoth Therapeutics, Inc.、Immuneering Corporation,振幅分别为64.75%、56.12%、41.52%。Rapt Therapeutics, Inc.公司简介:RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107230145a218ee81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107230145a218ee81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPT","BK4139","LENZ"],"gpt_icon":0},{"id":"2500148937","title":"Rapt Therapeutics, Inc.盘中异动 股价大涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500148937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500148937?lang=zh_cn&edition=full","pubTime":"2025-01-03 23:44","pubTimestamp":1735919049,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日23时44分,Rapt Therapeutics, Inc.股票出现波动,股价急速上涨5.52%。Rapt Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.52%。其相关个股中,Apollomics Inc C/Wts 01/04/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Scorpius Holdings, Inc.涨幅较大,Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃,换手率分别为1638.69%、1386.53%、301.09%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.,振幅分别为143.91%、107.01%、96.04%。Rapt Therapeutics, Inc.公司简介:RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010323440995f7de7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010323440995f7de7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RAPT"],"gpt_icon":0},{"id":"2500497166","title":"Rapt Therapeutics, Inc.盘中异动 下午盘快速拉升5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500497166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500497166?lang=zh_cn&edition=full","pubTime":"2025-01-01 03:08","pubTimestamp":1735672110,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日03时08分,Rapt Therapeutics, Inc.股票出现异动,股价大幅拉升5.25%。Rapt Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.26%。其相关个股中,知临集团、Onconetix, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大,Onconetix, Inc.、知临集团、Eyenovia, Inc.较为活跃,换手率分别为3055.80%、1954.35%、347.68%,振幅较大的相关个股有Onconetix, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、知临集团,振幅分别为265.45%、248.39%、236.89%。Rapt Therapeutics, Inc.公司简介:RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501010308309856c8c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501010308309856c8c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RAPT","LENZ","BK4139"],"gpt_icon":0},{"id":"2494385408","title":"Rapt Therapeutics, Inc.盘中异动 大幅上涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494385408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494385408?lang=zh_cn&edition=full","pubTime":"2024-12-27 22:32","pubTimestamp":1735309920,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日22时32分,Rapt Therapeutics, Inc.股票出现波动,股价急速上涨5.52%。Rapt Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.50%。Rapt Therapeutics, Inc.公司简介:RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。消息层面,截至22时32分,《HC Wainwright & Co.:上调RAPT Therapeutics评级》资讯为影响Rapt Therapeutics, Inc.的重要信息。该信息摘要如下:HC Wainwright&Co.:上调rapt therapeutics评级,由中性调整至买入评级,目标价由10.00美元调整至10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122722320195ef746c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122722320195ef746c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RAPT","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rapt.com","stockEarnings":[{"period":"1week","weight":0.0364},{"period":"1month","weight":0.2095},{"period":"3month","weight":1.6659},{"period":"6month","weight":2.6827},{"period":"1year","weight":3.0841},{"period":"ytd","weight":1.7271}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.0574},{"period":"6month","weight":0.1423},{"period":"1year","weight":0.1263},{"period":"ytd","weight":0.1677}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"RAPT Therapeutics, Inc.根据特拉华州法律于2015年3月注册成立。该公司是一家临床阶段,以免疫学为基础的生物制药公司,致力于发现,开发和商业化针对在肿瘤学和炎性疾病方面尚未得到充分满足的患者的口服小分子疗法。利用其专有的药物发现和开发引擎,该公司开发了高度选择性小分子,旨在调节这些疾病的关键免疫反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.064337},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.22623},{"month":3,"riseRate":0.833333,"avgChangeRate":0.02327},{"month":4,"riseRate":0,"avgChangeRate":-0.16676},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.061242},{"month":6,"riseRate":0.666667,"avgChangeRate":0.216374},{"month":7,"riseRate":0.666667,"avgChangeRate":0.062663},{"month":8,"riseRate":0.666667,"avgChangeRate":0.042508},{"month":9,"riseRate":0.333333,"avgChangeRate":0.195895},{"month":10,"riseRate":0.5,"avgChangeRate":-0.027693},{"month":11,"riseRate":0.571429,"avgChangeRate":0.058369},{"month":12,"riseRate":0.857143,"avgChangeRate":0.172443}],"exchange":"NASDAQ","name":"RAPT Therapeutics, Inc.","nameEN":"RAPT Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RAPT Therapeutics, Inc.(RAPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供RAPT Therapeutics, Inc.(RAPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"RAPT Therapeutics, Inc.,RAPT,RAPT Therapeutics, Inc.股票,RAPT Therapeutics, Inc.股票老虎,RAPT Therapeutics, Inc.股票老虎国际,RAPT Therapeutics, Inc.行情,RAPT Therapeutics, Inc.股票行情,RAPT Therapeutics, Inc.股价,RAPT Therapeutics, Inc.股市,RAPT Therapeutics, Inc.股票价格,RAPT Therapeutics, Inc.股票交易,RAPT Therapeutics, Inc.股票购买,RAPT Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RAPT Therapeutics, Inc.(RAPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供RAPT Therapeutics, Inc.(RAPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}